Publications by authors named "Temeka Dawn Lewis-Wolfson"
Background: To date, minimal data directly compare tocilizumab with baricitinib for treatment in moderate to severe COVID-19.
Objective: To compare the rates of in-hospital mortality with progression to mechanical ventilation in patients with COVID-19 who received either tocilizumab or baricitinib.
Methods: The authors conducted a single-centered, institutional review board-approved, retrospective cohort study.